| Identification | Back Directory | [Name]
propyl-delta(8)-tetrahydrocannabinol | [CAS]
31262-38-1 | [Synonyms]
Δ8-Tetrahydrocannabivarin
propyl-delta(8)-tetrahydrocannabinol
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6aR,10aR)- | [Molecular Formula]
C19H26O2 | [MOL File]
31262-38-1.mol | [Molecular Weight]
286.41 |
| Chemical Properties | Back Directory | [Boiling point ]
353.2±42.0 °C(Predicted) | [density ]
1.034±0.06 g/cm3(Predicted) | [storage temp. ]
-65 to -96°C | [solubility ]
DMF: 50 mg/ml
DMSO: 50 mg/ml
DMSO: PBS (pH 7.2) (1:3): 250µg/ml
Ethanol: 30 mg/ml
Methanol: 30 mg/ml | [pka]
9.81±0.60(Predicted) |
| Hazard Information | Back Directory | [Description]
Δ8-Tetrahydrocannabivarin is an analytical reference standard categorized as a cannabinoid.1 Δ8-Tetrahydrocannabivarin is regulated as a Schedule I compound in the United States. Δ8-Tetrahydrocannabivarin is provided as a DEA exempt preparation. This product is intended for research and forensic applications. | [Uses]
Δ8-Tetrahydrocannabivarin is a cannabinoid[1]. | [References]
1. Bátkai, S., Mukhopadhyay, P., Horváth, B., et al. Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors Br. J. Pharmacol. 165(8),2450-2461(2012). |
|
|